Patents by Inventor Mark C. Chappell

Mark C. Chappell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210024578
    Abstract: Angiotensin (1-7) analogs are provided. The analogs contain one or more substitutions with non-natural amino acid cis-3-(aminomethyl)cyclobutanecarboxylic acid (ACCA). Also provided are methods of making such analogs and methods for using such analogs as therapeutic compositions to treat or prevent various diseases or conditions.
    Type: Application
    Filed: July 1, 2020
    Publication date: January 28, 2021
    Inventors: Patricia E. Gallagher, E. Ann Tallant, Francesca Paradisi, Mark C. Chappell
  • Publication number: 20200216499
    Abstract: Angiotensin (1-7) analogs are provided. The analogs contain one or more substitutions with non-natural amino acid cis-3-(aminomethyl)cyclobutanecarboxylic acid (ACCA). Also provided are methods of making such analogs and methods for using such analogs as therapeutic compositions to treat or prevent various diseases or conditions.
    Type: Application
    Filed: December 12, 2016
    Publication date: July 9, 2020
    Applicants: WAKE FOREST UNIVERSITY HEALTH SCIENCES, UNIVERSITY COLLEGE DUBLIN
    Inventors: Patricia E. Gallagher, E. Ann Tallant, Francesca Paradisi, Mark C. Chappell